Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tipranavir

Next Previous
Drug Profile

Tipranavir

Alternative Names: Aptivus; Elodius; PNU 140690; Tipranivir

Latest Information Update: 25 Sep 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Developer Boehringer Ingelheim
  • Class Antivirals; Pyridines; Pyrones
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed HIV-1 infections

Most Recent Events

  • 28 Oct 2008 Drug interactions data of tipranavir co-administered with ritonavir and buprenorphine/naloxone and with valaciclovir presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America (ICAAC/IDSA-2008) ,
  • 06 Aug 2008 Preregistration for HIV-1 infections (treatment-experienced paediatric, adolescent and adult patients) in the European Union (PO, solution)
  • 06 Aug 2008 The 2-year follow-up efficacy data in paediatric patients with HIV-1 infections released by Boehringer-Ingelheim

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top